Continuing our Life-Long Commitment to Rare Disease Patients Around the World
As our global community continues to navigate the impact of COVID-19, CENTOGENE remains fully open and operational, underlining our continued commitment to patients globally.
ORDER ON CENTOPORTAL®

Back

SARS-CoV-2 Testing

Read more

CentoSwab™

Read more

Latest News

Read more

Img Alt Text

Transforming Global Genetic Data into Medical Decisions

We are a global leader in rare disease diagnosis and research by transforming real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies

Coronavirus Testing With CENTOGENE

Coronavirus Testing With CENTOGENE

Enabling you to get back to normal with our range of SARS-CoV-2 testing solutions for individuals and businesses

Read More

Improved Travel With Coronavirus Testing

Improved Travel With Coronavirus Testing

Reduce the risk of facing restrictions and quarantine measures at your destination with SARS-CoV-2 pre-flight testing at Frankfurt Airport

Read More

Improved Travel With Coronavirus Testing

The Latest Insights Into COVID-19

Keeping you up to date with the most recent news and scientific developments amid the Coronavirus pandemic

Read More

Our goal: providing precise medical diagnosis of inherited diseases at the earliest possible moment; transforming medical expertise and analytical information into actionable results for physicians, patients, and pharmaceutical partners.

Our commitment: life-long support for our patients and partners - driven by the continuous improvement of our diagnostic quality and therapeutic options for individual patients.

Latest Scientific News

Successful Monitoring of Gaucher Disease

Biomarkers are key tools in establishing a diagnosis and monitoring rare disorders. The…

Revealing Genetic Causes of Parkinson’s Disease

Certain variants in LRRK2 have been associated with Parkinson’s disease. While much is…

Testing of Novel Treatment Options for Niemann-Pick Disease

The search for causative treatments continues to be a leading challenge in rare disease…

A New Phenotype for a Known Neurological Disorder

Hereditary disorders of the nervous system may present with a wide spectrum of symptoms.…

Novel Causes for Heart Malformations

An ever-increasing number of genes have been linked to heart malformations. For ADAMTS19,…

Manifestation and Progression of an Ultra-Rare Disorder

Rarity is a major obstacle for comprehensively understanding certain genetic disorders,…

Clinical Expertise in Genetic Disorders

The fact that many lysosomal storage disorders may have a neurological component is…

Consanguinity and Recessive Disorders

High consanguinity is associated with a high prevalence of recessive genetic disorders.…

Genetics of the Blood-Brain Barrier

Proper function of the blood-brain barrier relies on the so-called tight junctions. In…

Insights Into an Ultra Rare Disease

Rarity of a disease usually correlates with a limited understanding. Case reports about…

Customer Feedback

Give feedback

Newsletter subscription

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, July 09, 2020 (GLOBE NEWSWIRE) - Centogene N.V. (Nasdaq: CNTG) (“Centogene” or the “Company”), a...

Read more

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, July 09, 2020 (Globe Newswire) - Centogene N.V. (Nasdaq: CNTG), a commercial-stage diagnostics and genetic...

Read more

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, July 07, 2020 (Globe Newswire) - Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare...

Read more

CAMBRIDGE, Mass. and SANTA MONICA, California, July 06, 2020 (Globe Newswire) – Centogene N.V. (Nasdaq: CNTG), a commercial-stage diagnostics and genetic...

Read more

Cambridge, MA, USA & Rostock/Berlin, Germany, July 2, 2020 (GLOBE NEWSWIRE) – Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases...

Read more

Cambridge, MA, USA & Rostock/Berlin, Germany, June 29, 2020 (Globe Newswire)

  • Lufthansa becomes first globally leading airline with a solution for safe and...
Read more

Cambridge, MA, USA & Rostock, Berlin, Deutschland, 29. Juni 2020

  • Richtungsweisende Kooperation bietet ab sofort das Testen von ankommenden und abfliegenden...
Read more

Cambridge, MA, USA & Rostock/Berlin, Germany, June 23, 2020 (Globe Newswire) – Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare...

Read more

Cambridge, MA, USA & Rostock/Berlin, Germany, June 15, 2020 (Globe Newswire) – Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare...

Read more